HomeCOLO-B • CPH
add
Coloplast A/S
Previous close
kr 866.20
Day range
kr 866.20 - kr 884.60
Year range
kr 689.20 - kr 977.60
Market cap
182.08B DKK
Avg Volume
189.58K
P/E ratio
-
Dividend yield
-
Primary exchange
CPH
In the news
Financials
Income Statement
Revenue
Net income
(DKK) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 6.88B | 12.72% |
Operating expense | 2.78B | 18.87% |
Net income | 1.27B | 0.16% |
Net profit margin | 18.50 | -11.19% |
Earnings per share | 0.09 | -98.53% |
EBITDA | 2.20B | 12.78% |
Effective tax rate | 21.89% | — |
Balance Sheet
Total assets
Total liabilities
(DKK) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 887.00M | 3.74% |
Total assets | 48.58B | 38.46% |
Total liabilities | 32.06B | 12.10% |
Total equity | 16.52B | — |
Shares outstanding | 224.84M | — |
Price to book | 11.79 | — |
Return on assets | 9.67% | — |
Return on capital | 11.44% | — |
Cash Flow
Net change in cash
(DKK) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 1.27B | 0.16% |
Cash from operations | 1.49B | 27.46% |
Cash from investing | -350.00M | -27.74% |
Cash from financing | -1.15B | -74.96% |
Net change in cash | -2.00M | -100.88% |
Free cash flow | 1.01B | 19.51% |
About
Coloplast A/S is a Danish multinational company that develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care. Wikipedia
Founded
1957
Headquarters
Website
Employees
16,019